| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 |
|---|
| 470 | 470 | 324 | |
Expenses | |||
| 116 | 162 | 100 | |
| 116 | 162 | 100 | |
Profit | |||
| 586 | 632 | 425 | |
| 492 | 544 | 425 | |
Per share | |||
| ₹5.31 | ₹5.88 | ₹4.62 | |
Revenue detail — as filed | |||
| 10,377 | 10,197 | 9,480 | |
| 1,351 | 1,313 | 1,109 | |
Expense detail — as filed | |||
| 377 | 368 | 322 | |
| 2,387 | 2,344 | 2,228 | |
| 2,387 | 2,344 | 2,228 | |
| 572 | 566 | 406 | |
| 12.0 | 10.2 | 0.0 | |
Profit build-up — alternate / pre-Ind-AS tags | |||
| 586 | 632 | 425 | |
| 586 | 632 | 425 | |
| 94.1 | 87.3 | 0.0 | |
| 492 | 544 | 425 | |
| 86.4 | 544 | 425 | |
Per share — as-filed variants | |||
| ₹0.93 | ₹5.89 | ₹4.65 | |
| ₹0.93 | ₹5.88 | ₹4.62 | |
Appropriations & transfers | |||
| 867 | 917 | 615 | |
| 3,811 | — | — | |
Insurance — revenue account (Policyholders') | |||
| 8,556 | 8,414 | 8,046 | |
| 11,043 | 11,294 | 10,282 | |
| 8,465 | 8,321 | 8,231 | |
| 829 | 803 | 778 | |
| 560 | 556 | 406 | |
| 4,631 | 4,487 | 3,872 | |
| 6,294 | 6,133 | 5,859 | |
| 1,662 | 1,646 | 1,987 | |
| — | 4,782 | 3,639 | |
| — | 12,470 | 10,412 | |
Insurance — Shareholders' account | |||
| 1,158 | 1,198 | 831 | |
| 290 | 278 | 216 | |
| 867 | 917 | 615 | |
| 0.0 | 0.1 | 0.1 | |
| 0.0 | 0.1 | 0.1 | |
Insurance — result & transfers | |||
| −954 | −866 | −819 | |
| 867 | 917 | 615 | |
| 2.0 | 2.4 | 0.4 | |
Insurance — IRDAI ratios (as filed, not percentages) | |||
| 2.42× | 2.42× | 2.24× | |
| ₹0.02 | ₹2.42 | ₹0.02 | |
| ₹1.12 | ₹1.11 | ₹1.09 | |
| ₹0.73 | ₹0.73 | ₹0.73 | |
| ₹0.77 | ₹0.74 | ₹0.80 | |
| ₹0.39 | ₹0.41 | ₹0.39 | |
Direct-method operating receipts — filed in the P&L block | |||
| — | 1,052 | 883 | |
Regulatory disclosures — filed alongside, not part of the P&L | |||
| ₹1.00 | ₹1.00 | ₹116.00 | |
| ₹1.00 | ₹1.00 | ₹116.00 | |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|
| Other Income | — | 324.5 | 470.2 | 470.3 | |
| Expenses | |||||
| EBITDA | — | 100.5 | 161.5 | 116.2 | |
| EBIT | — | 100.5 | 161.5 | 116.2 | |
| Profit | |||||
| Pretax Income | — | 424.9 | 631.7 | 586.5 | |
| Net Income | — | 424.9 | 544.4 | 492.4 | |
| Per Share | |||||
| Basic EPS | — | 4.62 | 5.88 | 5.31 | |
| Revenue Detail — as filed | |||||
| + Operating Income | — | 9,479.5 | 10,197.2 | 10,377.1 | |
| + Income from Investments (net) | — | 1,109.1 | 1,312.7 | 1,350.5 | |
| Expense Detail — as filed | |||||
| + Employee Remuneration & Welfare | — | 321.5 | 368.3 | 377.4 | |
| + Commission (net) | — | 2,228.4 | 2,344.2 | 2,387.3 | |
| + Commission & Brokerage (net) | — | 2,228.4 | 2,344.2 | 2,387.3 | |
| + Non-operating Expense | — | 405.7 | 566.3 | 571.9 | |
| + Non-operating Provision — Doubtful Debts | — | 0.0 | 10.2 | 12.0 | |
| Profit Build-up — Alternate / Pre-Ind-AS Tags | |||||
| Profit before Extraordinary Items | — | 424.9 | 631.7 | 586.5 | |
| Profit / (Loss) before Tax — alt tag | — | 424.9 | 631.7 | 586.5 | |
| + Provision for Tax | — | 0.0 | 87.3 | 94.1 | |
| Profit / (Loss) after Tax | — | 424.9 | 544.4 | 492.4 | |
| Profit Carried to Balance Sheet | — | 424.9 | 544.4 | 86.4 | |
| Per Share — as-filed variants | |||||
| Basic & Diluted EPS before Extraordinary (not annualised) | — | 4.65 | 5.89 | 0.93 | |
| Basic & Diluted EPS after Extraordinary (not annualised) | — | 4.62 | 5.88 | 0.93 | |
| Appropriations & Transfers | |||||
| + Transfer to Profit & Loss Account | — | 614.6 | 917.4 | 866.9 | |
| Reserves & Surplus excl. Revaluation Reserve | — | — | — | 3,811.0 | |
| Insurance — Revenue Account (Policyholders') | |||||
| Premium Earned | — | 8,046.0 | 8,414.3 | 8,556.3 | |
| + Gross Premiums Written | — | 10,282.1 | 11,294.1 | 11,043.2 | |
| + Net Premium Written | — | 8,230.8 | 8,321.3 | 8,464.9 | |
| + Operating Expenses — Insurance Business | — | 777.6 | 802.6 | 829.4 | |
| + Non-operating Expenses — Non-insurance | — | 405.7 | 556.1 | 559.9 | |
| + Claims Paid | — | 3,871.7 | 4,487.2 | 4,631.2 | |
| + Incurred Claims | — | 5,859.0 | 6,133.0 | 6,293.6 | |
| + Change in Outstanding Claims | — | 1,987.3 | 1,645.9 | 1,662.4 | |
| + Payments — Premiums, Claims, Annuities & Benefits | — | 3,638.6 | 4,781.8 | — | |
| + Receipts — Premiums, Claims, Annuities & Benefits | — | 10,411.7 | 12,470.2 | — | |
| Insurance — Shareholders' Account | |||||
| + Income — Shareholders' Account | — | 830.6 | 1,198.0 | 1,158.4 | |
| + Shareholders' Investment Income | — | 215.7 | 278.2 | 289.5 | |
| + Transfer from Policyholders' Fund | — | 614.6 | 917.4 | 866.9 | |
| With Unrealised Gains | — | 0.1 | 0.1 | 0.0 | |
| Without Unrealised Gains | — | 0.1 | 0.1 | 0.0 | |
| Insurance — Result & Transfers | |||||
| Underwriting Profit / (Loss) | — | -819.0 | -865.5 | -953.9 | |
| Operating Profit / (Loss) | — | 614.6 | 917.4 | 866.9 | |
| + Other Income — Shareholders' Account | — | 0.4 | 2.4 | 2.0 | |
| Insurance — IRDAI Ratios (as filed, not percentages) | |||||
| Solvency Ratio (x, one scale) | — | 2.24 | 2.42 | 2.42 | |
| Solvency Ratio (as filed) | — | 0.02 | 2.42 | 0.02 | |
| Combined Ratio | — | 1.09 | 1.11 | 1.12 | |
| Incurred Claim Ratio | — | 0.73 | 0.73 | 0.73 | |
| Net Retention Ratio | — | 0.80 | 0.74 | 0.77 | |
| Expenses of Management Ratio | — | 0.39 | 0.41 | 0.39 | |
| Direct-method Operating Receipts — filed in the P&L block | |||||
| + Other Operating Cash Payments | — | 883.4 | 1,051.9 | — | |
| Regulatory Disclosures — filed alongside, not part of the P&L | |||||
| Investor Complaints — Received | — | 116.00 | 1.00 | 1.00 | |
| Investor Complaints — Disposed | — | 116.00 | 1.00 | 1.00 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||||
| Operating Expenses | — | 8,865.0 | 9,279.8 | 9,510.2 | |
| Other Operating Expenses | — | 456.1 | 434.3 | 451.9 | |